Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
出版年份 2013 全文链接
标题
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
作者
关键词
-
出版物
CARCINOGENESIS
Volume 35, Issue 5, Pages 1012-1019
出版商
Oxford University Press (OUP)
发表日期
2013-12-11
DOI
10.1093/carcin/bgt404
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers
- (2013) Juliet D. French et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Genetic Susceptibility to Triple-Negative Breast Cancer
- (2013) K. N. Stevens et al. CANCER RESEARCH
- Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) Promotes Growth and Survival of Breast Epithelial Cells: Novel Regulation of the Estrogen Receptor
- (2013) Emily J. Foulstone et al. ENDOCRINOLOGY
- Genome-wide association studies identify four ER negative–specific breast cancer risk loci
- (2013) Montserrat Garcia-Closas et al. NATURE GENETICS
- Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
- (2013) Stig E Bojesen et al. NATURE GENETICS
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk
- (2013) Kyriaki Michailidou et al. NATURE GENETICS
- Comprehensive Functional Annotation of Seventy-One Breast Cancer Risk Loci
- (2013) Suhn Kyong Rhie et al. PLoS One
- 19p13.1 Is a Triple-Negative-Specific Breast Cancer Susceptibility Locus
- (2012) K. N. Stevens et al. CANCER RESEARCH
- A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11
- (2012) Afshan Siddiq et al. HUMAN MOLECULAR GENETICS
- TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model
- (2011) Jing Liu et al. BMC DEVELOPMENTAL BIOLOGY
- Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor-Positive, Lower Grade Breast Cancer
- (2011) R. L. Milne et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer
- (2011) K. N. Stevens et al. CANCER RESEARCH
- Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
- (2011) Annegien Broeks et al. HUMAN MOLECULAR GENETICS
- Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium†
- (2011) Jonine D. Figueroa et al. HUMAN MOLECULAR GENETICS
- A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer
- (2011) Christopher A Haiman et al. NATURE GENETICS
- HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants
- (2011) L. D. Ward et al. NUCLEIC ACIDS RESEARCH
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers
- (2009) Sharon Nofech-Mozes et al. BREAST CANCER RESEARCH AND TREATMENT
- Parathyroid Hormone-Related Protein Protects against Mammary Tumor Emergence and Is Associated with Monocyte Infiltration in Ductal Carcinoma In situ
- (2009) N. I. Fleming et al. CANCER RESEARCH
- SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap
- (2008) A. D. Johnson et al. BIOINFORMATICS
- TBX3 Is Overexpressed in Breast Cancer and Represses p14ARF by Interacting with Histone Deacetylases
- (2008) W. Yarosh et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started